Stock listing
DYN Stock Price, News, Filings & Events — Dyne Therapeutics, Inc.
Selected listing: DYN · BOATS · USD · US
This page tracks Dyne Therapeutics, Inc.'s DYN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DYN:BOATS. DYN:BOATS is the stock-level entry point for investors researching Dyne Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.

- Ticker
- DYN:BOATS
- Asset type
- Stock
- Market cap
- $3.40B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
Dyne Therapeutics, Inc. DYN:BOATS stock context
This page tracks Dyne Therapeutics, Inc.'s DYN:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following DYN:BOATS. DYN:BOATS is the stock-level entry point for investors researching Dyne Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Dyne Therapeutics, Inc. (ticker: DYN) is a publicly traded company based in the United States, with a market capitalization of approximately $4.49 billion. The company focuses on developing innovative therapies for serious diseases, leveraging its proprietary technology platform. Dyne Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Dyne Therapeutics, Inc.
Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NM...
September 3, 2026
Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
July 29, 2026
Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular...
July 28, 2026
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
July 21, 2026
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dys...
July 20, 2026
Research Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for DYN:BOATS.
Dyne Therapeutics, Inc. company profile
View the public company page for Dyne Therapeutics, Inc. on 6ix.
Dyne Therapeutics, Inc. news
Read company news and market updates connected to Dyne Therapeutics, Inc..
Dyne Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Dyne Therapeutics, Inc..